Description

Capetero 500 mg contains Capecitabine, an oral fluoropyrimidine carbamate that is selectively activated within tumor tissues. It is commonly used as monotherapy or in combination with other chemotherapy agents in various solid tumors.

🔬 Mechanism of Action

Capecitabine is converted in the body to its active form, 5-fluorouracil (5-FU). Once activated, it:

• Inhibits thymidylate synthase
• Disrupts DNA synthesis
• Interferes with RNA processing
• Leads to cancer cell death

Because the conversion occurs preferentially in tumor tissues, it allows more targeted cytotoxic activity.

💊 Indications Capetero 500 mg

Capetero 500 mg is indicated for:

• Metastatic Colorectal Cancer
• Adjuvant treatment of Colon Cancer
• Metastatic Breast Cancer (alone or in combination therapy)
• Gastric Cancer (as part of combination regimens)

📌 Key Features of Capetero 500 mg

• Strength: 500 mg
• Dosage Form: Oral tablet
• Therapeutic Class: Antimetabolite Chemotherapy (Fluoropyrimidine)
• Administration: Taken orally within 30 minutes after meals
• Typical Schedule: Often given for 14 days followed by 7 days rest (21-day cycle), as prescribed
• Monitoring: Regular complete blood count (CBC) and liver function tests required

⚕️ Benefits of Capecitabine

• Oral chemotherapy for convenience
• Tumor-targeted activation
• Effective in both adjuvant and metastatic settings
• Can be combined with other anticancer therapies

⚠️ Precautions

• Risk of hand-foot syndrome
• Diarrhea, nausea, and mucositis may occur
• Bone marrow suppression possible
• Dose adjustments required in renal impairment
• Use strictly under oncologist supervision

Capetero 500 mg (Capecitabine Tablets) provides an effective oral chemotherapy option for colorectal, breast, and gastric cancers, offering targeted tumor activity and convenient dosing when administered under expert oncology care.